Immune Reconstitution Kinetics as an Early Predictor for Mortality using Various Hematopoietic Stem Cell Sources in Children

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 2, 2013, Pages 305-313

  Bartelink, Imke Heleen ^a,d   Belitser, Svetlana V ^b   Knibbe, Catherijne A J ^c,d   Danhof, Meindert ^d   de Pagter, Anne J ^a   Egberts, Toine C G ^a,b   Boelens, Jaap Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Bone marrow transplantation; CD4+ cell NK cells; Cord blood transplantation; Identical sibling transplantation; Immune recovery; Modeling; Predictor

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW; BONE MARROW TRANSPLANTATION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; EVENT FREE SURVIVAL; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HAZARD RATIO; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; LYMPHOCYTE; LYMPHOCYTE RECONSTITUTION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MEMBRANE RECONSTITUTION; NATURAL KILLER CELL; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SIBLING; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; T LYMPHOCYTE; UMBILICAL CORD BLOOD; UNIVERSITY HOSPITAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INFANT; MALE; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84872564060     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.10.010     Document Type: Article

References (56)

1. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
2. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
3. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-1178.
4. Herr A.L., Kabbara N., Bonfim C.M., et al. Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT. Blood 2010, 116:1849-1856.
5. Barker J.N., Davies S.M., DeFor T., et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001, 97:2957-2961.
6. Szabolcs P. T-lymphocyte recovery and function after cord blood transplantation. Immunol Res 2011, 49:56-69.
7. Storek J., Gooley T., Witherspoon R.P., et al. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997, 54:131-138.
8. Savani B.N., Mielke S., Rezvani K., et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13:1216-1223.
9. Parkman R., Cohen G., Carter S.L., et al. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant 2006, 12:919-927.
10. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004, 351:2265-2275.
11. 6/L at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006, 37:1119-1128.
12. Fries B.C., Khaira D., Pepe M.S., et al. Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients. Exp Hematol 1993, 21:1387-1392.
13. Einsele H., Ehninger G., Steidle M., et al. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 1993, 82:1672-1678.
14. + cell count and transplant-related mortality. Bone Marrow Transplant 2008, 41:55-62.
15. Ferrara J.L., Levine J.E., Reddy P., et al. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
16. Levine J.E. Implications of TNF-α in the pathogenesis and management of GVHD. Int J Hematol 2011, 93(5):571-577.
17. Schultz K.R., Miklos D.B., Fowler D., et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, III. Biomarker Working Group Report. Biol Blood Marrow Transplant 2006, 12:126-137.
18. + selected PBPC grafts unselected PBPC grafts or BM grafts. Bone Marrow Transplant 1999, 24:295-302.
19. de Vries E., van Tol M.J., van den Bergh R.L., et al. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation. Bone Marrow Transplant 2000, 25:267-275.
20. Kalwak K., Gorczynska E., Toporski J., et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 2002, 118:74-89.
21. Maury S., Mary J.Y., Rabian C., et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001, 115:630-641.
22. Small T.N., Avigan D., Dupont B., et al. Immune reconstitution following T cell-depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant 1997, 3:65-75.
23. Small T.N., Papadopoulos E.B., Boulad F., et al. Comparison of immune reconstitution after unrelated and related T cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999, 93:467-480.
24. Szabolcs P., Niedzwiecki D. Immune reconstitution in children after unrelated cord blood transplantation. Biol Blood Marrow Transplant 2008, 14:66-72.
25. Szabolcs P., Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007, 9:111-122.
26. Kim D.H., Kim J.G., Sohn S.K., et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 2004, 125:217-224.
27. Baird K., Cooke K., Schultz K.R. Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am 2010, 57:297-322.
28. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332:143-149.
29. Fujii H., Cuvelier G., She K., et al. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood 2008, 111:3276-3285.
30. Koehl U., Bochennek K., Zimmermann S.Y., et al. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8(+)CD3(+) count reconstitution is associated with survival. Bone Marrow Transplant 2007, 39:269-278.
31. Koenig M., Huenecke S., Salzmann-Manrique E., et al. Multivariate analyses of immune reconstitution in children after allo-SCT: risk estimation based on age-matched leukocyte sub-populations. Bone Marrow Transplant 2010, 45:613-621.
32. van Gent R., van Tilburg C.M., Nibbelke E.E., et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol 2009, 133:95-107.
33. Heagerty P.J., Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics 2005, 61:92-105.
34. Saha P, Heagerty PJ, Zheng Y. Introduction to RisksetROC. 1-17-2011. Ref Type: Internet Communication.
35. Peggs K.S., Mackinnon S. Immune reconstitution following haematopoietic stem cell transplantation. Br J Haematol 2004, 124:407-420.
36. Komanduri K.V., St John L.S., de Lima M., et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007, 110:4543-4551.
37. Talvensaari K., Clave E., Douay C., et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002, 99:1458-1464.
38. Niehues T., Rocha V., Filipovich A.H., et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children: a Eurocord analysis. Br J Haematol 2001, 114:42-48.
39. Thomson B.G., Robertson K.A., Gowan D., et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000, 96:2703-2711.
40. Rubio M.T., Moreira-Teixeira L., Bachy E., et al. Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival. Blood 2012, 120:2144-2154.
41. Ickovics J.R., Hamburger M.E., Vlahov D., et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001, 285:1466-1474.
42. Katzenstein D.A., Hammer S.M., Hughes M.D., et al. AIDS Clinical Trials Group Study 175 Virology Study Team. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996, 335:1091-1098.
43. Wood E., Hogg R.S., Yip B., et al. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?. AIDS 2003, 17:711-720.
44. Kook H., Goldman F., Padley D., et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996, 88:1089-1097.
45. Larosa F., Marmier C., Robinet E., et al. Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation. Bone Marrow Transplant 2005, 35:859-868.
46. Pearl J.P., Parris J., Hale D.A., et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005, 5:465-474.
47. Pavletic Z.S., Joshi S.S., Pirruccello S.J., et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 1998, 21:33-41.
48. + T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 2007, 109:2086-2088.
49. Malaspina A., Moir S., Ho J., et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci USA 2006, 103:2262-2267.
50. Kim Y.J., Broxmeyer H.E. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol 2011, 79:112-126.
51. Liao Y., Geyer M.B., Yang A.J., et al. Cord blood transplantation and stem cell regenerative potential. Exp Hematol 2011, 39:393-412.
52. Peters C., Cornish J.M., Parikh S.H., et al. Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia. Pediatr Clin North Am 2010, 57:27-46.
53. Eapen M., Rubinstein P., Zhang M.J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007, 369:1947-1954.
54. Schellekens J., Rozemuller E.H., Petersen E.J., et al. Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation. Mol Immunol 2008, 45:981-989.
55. Bartelink I.H., Flinsenberg T.W.H., Versluys C.A., et al. Busulfan + fludarabine: an effective and low toxic conditioning regimen prior to HSCT in children with either malignant or non-malignant diseases [abstract]. Biol Blood Marrow Transplant 2011, 17:S259.
56. Bartelink I.H., Bredius R.G., Belitser S.V., et al. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation. Biol Blood Marrow Transplant 2009, 15:231-241.